Vertiv Holdings Co (BMV:VRT)
2,675.00
-79.54 (-2.89%)
At close: Aug 1, 2025, 2:00 PM CST
CTI BioPharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 812.3 | 495.8 | 460.2 | 76.6 | 119.6 | -327.3 | Upgrade |
Depreciation & Amortization | 284.8 | 277 | 271 | 302.4 | 227 | 203.1 | Upgrade |
Other Amortization | 7.2 | 7 | 7.9 | 7.5 | 6.3 | 10.5 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | - | -3.7 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 8.7 | 21 | Upgrade |
Stock-Based Compensation | 41.4 | 34.6 | 25 | 24.7 | 23.2 | 13 | Upgrade |
Other Operating Activities | 258.3 | 390.8 | 69.7 | -111.1 | -41.1 | 349.4 | Upgrade |
Change in Accounts Receivable | -546 | -280.3 | -277.2 | -368 | -117.4 | - | Upgrade |
Change in Inventory | -282.7 | -369.3 | -54 | -211.4 | -125.7 | - | Upgrade |
Change in Accounts Payable | 482.3 | 343.1 | -17.7 | 132.8 | 105.1 | - | Upgrade |
Change in Unearned Revenue | 351.3 | 434.5 | 274.2 | 67.6 | 55.3 | - | Upgrade |
Change in Income Taxes | 102.2 | 42.8 | 45.2 | -11.6 | -8.8 | - | Upgrade |
Change in Other Net Operating Assets | -84.6 | -56.7 | 96.2 | -58.6 | -41.3 | -60.8 | Upgrade |
Operating Cash Flow | 1,427 | 1,319 | 900.5 | -152.8 | 210.9 | 208.9 | Upgrade |
Operating Cash Flow Growth | 26.92% | 46.51% | - | - | 0.96% | 263.30% | Upgrade |
Capital Expenditures | -178.6 | -167 | -127.9 | -100 | -73.4 | -44.4 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 12.4 | 3.9 | 9.8 | 7 | Upgrade |
Cash Acquisitions | -17.6 | -17.6 | -28.8 | -5 | -1,164 | - | Upgrade |
Divestitures | - | - | 11.9 | - | 21.7 | - | Upgrade |
Sale (Purchase) of Intangibles | -8.7 | -17.1 | -6.7 | -11 | -11.2 | -8.3 | Upgrade |
Investing Cash Flow | -303 | -201.7 | -139.1 | -112.1 | -1,217 | -45.7 | Upgrade |
Long-Term Debt Issued | - | 270 | 224.9 | 790.8 | 850 | 2,535 | Upgrade |
Total Debt Issued | - | 270 | 224.9 | 790.8 | 850 | 2,535 | Upgrade |
Long-Term Debt Repaid | - | -291.1 | -487 | -572.2 | -21.8 | -3,950 | Upgrade |
Total Debt Repaid | -21 | -291.1 | -487 | -572.2 | -21.8 | -3,950 | Upgrade |
Net Debt Issued (Repaid) | -21 | -21.1 | -262.1 | 218.6 | 828.2 | -1,415 | Upgrade |
Issuance of Common Stock | 22.4 | 33 | 27.4 | 3.1 | 111.6 | 156.5 | Upgrade |
Repurchase of Common Stock | -7.8 | -621.8 | -3.3 | -4.3 | -7.3 | - | Upgrade |
Common Dividends Paid | -51.9 | -42.2 | -9.5 | -3.8 | -3.8 | -3.3 | Upgrade |
Other Financing Activities | - | - | - | -113.4 | -13.8 | 1,403 | Upgrade |
Financing Cash Flow | -58.3 | -652.1 | -247.5 | 100.2 | 914.9 | 140.7 | Upgrade |
Foreign Exchange Rate Adjustments | 3.1 | -21.9 | 1.5 | -9.2 | -4.5 | 5 | Upgrade |
Net Cash Flow | 1,068 | 443.6 | 515.4 | -173.9 | -95.5 | 308.9 | Upgrade |
Free Cash Flow | 1,248 | 1,152 | 772.6 | -252.8 | 137.5 | 164.5 | Upgrade |
Free Cash Flow Growth | 27.38% | 49.15% | - | - | -16.41% | 1561.62% | Upgrade |
Free Cash Flow Margin | 13.72% | 14.38% | 11.26% | -4.44% | 2.75% | 3.76% | Upgrade |
Free Cash Flow Per Share | 3.22 | 2.98 | 2.00 | -0.67 | 0.38 | 0.54 | Upgrade |
Cash Interest Paid | 155.5 | 155.5 | 176.7 | 132.8 | 75.1 | 167 | Upgrade |
Cash Income Tax Paid | 272.5 | 272.5 | 153 | 104.6 | 97.3 | 64.7 | Upgrade |
Levered Free Cash Flow | 626.91 | 1,036 | 716.54 | -280.64 | 127.23 | 294.65 | Upgrade |
Unlevered Free Cash Flow | 690.46 | 1,123 | 821.2 | -196.08 | 177.55 | 364.84 | Upgrade |
Change in Net Working Capital | 439.5 | -130.4 | -86.3 | 554.3 | 158.8 | 8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.